Stem cell research

pediatric cardiology

faseb journal : official publication of the federation of american societies for experimental biology

stem cell research & therapy

molecular therapy methods & clinical development

intractable & rare diseases research

Molecular autism

differentiation; research in biological diversity

equine veterinary journal

bjs open

[1] Increased Ca signaling in neurons derived from ASD induced pluripotent stem cells.

[2] Immune potential of allogeneic equine induced pluripotent stem cells.

[3] Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.

[4] Recapitulating idiopathic pulmonary fibrosis related alveolar epithelial dysfunction in a human iPSC-derived air-liquid interface model.

[5] Association of bacteria in pancreatic fistula fluid with complications after pancreatic surgery.

[6] recent progress in the regeneration of spinal cord injuries by induced pluripotent stem cells

[7] pluripotent stem cells induced to neural lineages and neural tissues.

[8] the model of distributor chain financing based on buy back guarantee contract

[9] development of gonadotropin-releasing hormone-secreting neurons from human pluripotent stem cells

[10] research on induced pluripotent stem cells and the application in ocular tissues

[11] rapid generation of human genetic loss-of-function ipsc lines by simultaneous reprogramming and gene editing

[12] the state of play with ipscs and spinal cord injury models

[13] advancing stem cell models of alpha-synuclein gene regulation in neurodegenerative disease

[14] rapid generation of sub-type, region-specific neurons and neural networks from human pluripotent stem cell-derived neurospheres

[15] prospects and challenges of induced pluripotent stem cells in equine health

[16] mucosal-associated invariant t cells in regenerative medicine

[17] Genotyping, generation and proteomic profiling of the first human autosomal dominant osteopetrosis type II-specific induced pluripotent stem cells.

[18] Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods.

[19] Applying hydrodynamic pressure to efficiently generate induced pluripotent stem cells via reprogramming of centenarian skin fibroblasts.

[20] Reference Transcriptome for Deriving Marmoset Induced Pluripotent Stem Cells.

[21] Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts.

[22] Generation of transgene-free porcine intermediate type induced pluripotent stem cells.

[23] Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.

[24] Oral Mucosa-Derived Induced Pluripotent Stem Cells from Patients with Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome.

[25] Optimizing the method for generation of integration-free induced pluripotent stem cells from human peripheral blood.

[26] Generation of urine-derived induced pluripotent stem cells from a patient with phenylketonuria.

[27] Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells.

[28] Comparative characterization of human induced pluripotent stem cells (hiPSC) derived from patients with schizophrenia and autism

[29] Chimeric G-CSF Receptor-Mediated STAT3 Activation Contributes to Efficient induction of Cardiomyocytes from Mouse Induced Pluripotent Stem Cells.

[30] Recent advances of induced pluripotent stem cells application in neurodegenerative diseases

[31] Three-dimensional decellularized amnion membrane scaffold promotes the efficiency of male germ cells generation from human induced pluripotent stem cells.

[32] Strategies for the expansion of human induced pluripotent stem cells as aggregates in single-use Vertical-Wheel™ bioreactors.

[33] Effect of different feeding schedules on the survival and neural differentiation of human embryonic and induced pluripotent stem cells

[34] Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient-derived induced pluripotent stem cells for future research

[35] Efficient Production of Hepatocyte-like Cells from Human-induced Pluripotent Stem Cells by Optimizing Growth Factors

[36] Improved methods for the differentiation of hypothalamic vasopressin neurons using mouse induced pluripotent stem cells.

[37] Micro-Engineered Models of Development Using Induced Pluripotent Stem Cells.

[38] Increased Ca signaling in neurons derived from ASD induced pluripotent stem cells.

[39] A hybrid microfluidic system for regulation of neural differentiation in induced pluripotent stem cells.

[40] Immune potential of allogeneic equine induced pluripotent stem cells.

[41] Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.

[42] Extracellular Vesicles Derived from Induced Pluripotent Stem Cells Promote Renoprotection in Acute Kidney Injury Model.

[43] In vitro modelling of alveolar repair at the air-liquid interface using alveolar epithelial cells derived from human induced pluripotent stem cells

[44] Therapeutic efficacy of catalpol against apoptosis in cardiomyocytes derived from human induced pluripotent stem cells

[45] Author Correction: Role of astroglia in Down’s syndrome revealed by patient-derived human-induced pluripotent stem cells (Nature Communications, (2014), 5, 1, (4430), 10.1038/ncomms5430)

[46] melanin transfer in human 3d skin equivalents generated exclusively from induced pluripotent stem cells.

[47] differentiation of induced pluripotent stem cells into male germ cells in vitro through embryoid body formation and retinoic acid or testosterone induction

[48] generation of induced pluripotent stem cells (aro-ipsc1-11) from a patient with autosomal recessive osteopetrosis harboring the c.212 + 1g > t mutation in snx10 gene

[49] recent progress in the regeneration of spinal cord injuries by induced pluripotent stem cells

[50] efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells

[51] factor-reduced human induced pluripotent stem cells efficiently differentiate into neurons independent of the number of reprogramming factors

[52] establishment of mui009 – a human induced pluripotent stem cells from a 32 year old male with homozygous β°-thalassemia coinherited with heterozygous α-thalassemia 2

[53] rock inhibitor primes human induced pluripotent stem cells to selectively differentiate towards mesendodermal lineage via epithelial-mesenchymal transition-like modulation

[54] putative epimutagens in maternal peripheral and cord blood samples identified using human induced pluripotent stem cells

[55] inflammatory responses and barrier function of endothelial cells derived from human induced pluripotent stem cells

[56] targeted correction and restored function of the cftr gene in cystic fibrosis induced pluripotent stem cells

[57] scalable generation of universal platelets from human induced pluripotent stem cells

[58] the promise and challenge of induced pluripotent stem cells for cardiovascular applications

[59] research on induced pluripotent stem cells and the application in ocular tissues

[60] a panel of cpg methylation sites distinguishes human embryonic stem cells and induced pluripotent stem cells

[61] cgmp-manufactured human induced pluripotent stem cells are available for pre-clinical and clinical applications

[62] mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives

[63] comparison of 2d and 3d neural induction methods for the generation of neural progenitor cells from human induced pluripotent stem cells

[64] reprogramming human endometrial fibroblast into induced pluripotent stem cells

[65] ctip-specific roles during cell reprogramming have long-term consequences in the survival and fitness of induced pluripotent stem cells

[66] vaccination with human induced pluripotent stem cells creates an antigen-specific immune response against hiv-1 gp160

[67] generation of induced pluripotent stem cells from a patient with parkinson's disease carrying lrrk2 p.i2012t mutation

[68] generation of induced pluripotent stem cells (ipscs) from a hereditary spastic paraplegia patient carrying a homozygous y275x mutation in cyp7b1 (spg5)

[69] comparative study of human embryonic stem cells (hesc) and human induced pluripotent stem cells (hipsc) as a treatment for retinal dystrophies

[70] prospects and challenges of induced pluripotent stem cells in equine health